Xue Jun Su
Director/Board Member bij SSY GROUP LIMITED
Vermogen: 16 M $ op 31-03-2024
Profiel
Xue Jun Su is currently an Executive Director at SSY Group Ltd.
and New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
Previously, he worked as Deputy Chairman at Shijiazhuang No.
4 Pharmaceutical Co., Ltd.
and as a Factory Manager at Shijiazhuang No 1 Pharmaceutical Factory.
Mr. Su obtained an undergraduate degree from Hebei Normal University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SSY GROUP LIMITED
0.82% | 30-06-2023 | 24 416 000 ( 0.82% ) | 16 M $ | 31-03-2024 |
Actieve functies van Xue Jun Su
| Bedrijven | Functie | Begin |
|---|---|---|
| SSY GROUP LIMITED | Director/Board Member | 15-12-2014 |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
 New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The private company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Director/Board Member | 07-01-2007 |
Eerdere bekende functies van Xue Jun Su
| Bedrijven | Functie | Einde |
|---|---|---|
| Shijiazhuang No 1 Pharmaceutical Factory | Corporate Officer/Principal | - |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Chairman | - |
Opleiding van Xue Jun Su
| Hebei Normal University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SSY GROUP LIMITED | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The private company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
| Shijiazhuang No 1 Pharmaceutical Factory |
